JOSÉ
HERNÁNDEZ QUERO
Investigador desde 2023
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (2)
2017
-
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
The Lancet HIV, Vol. 4, Núm. 12, pp. e536-e546
2009
-
Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment
Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 12, pp. 5185-5196